Navigation Links
Codexis Names Fernando Valle Research Fellow
Date:11/4/2009

REDWOOD CITY, Calif., Nov. 4 /PRNewswire/ -- Codexis, Inc. today announced that Fernando Valle, Ph.D., has joined the company as Codexis' first Research Fellow. Dr. Valle, a distinguished researcher in metabolic and genetic engineering over a nearly 30-year career in industrial biotechnology, will focus on Codexis' advanced biofuels programs. He will report to Lori Giver, Ph.D., Vice President, Synthetic Biology.

Dr. Valle joins Codexis from LS9, where he was Senior Director, Metabolic Engineering. Previously, he held a series of senior research positions with Genencor over 10 years, including Director, Metabolic Pathway Engineering. He holds a Ph.D in molecular biology and biotechnology from the National University of Mexico, and also held research positions at that university's Institute of Biotechnology. He is named on 14 issued U.S. patents and is an author on more than 50 scientific articles in the genetic engineering field.

"Fernando Valle is one of our industry's leading experts in metabolic engineering and in developing technology for real world commercial applications," said David Anton, Ph.D., Senior Vice President, Research and Development. "While at Genencor, he played a pivotal role in developing the successful metabolic pathway leading to commercial scale production of the chemical intermediate 1,3-propanediol (PDO, used in a wide variety of industrial applications ranging from carpet to airplane deicing fluids). We are delighted to welcome him to Codexis and our research leadership team. Codexis' ability to attract world class talent like Fernando is a clear indication of our preeminent position in cellular engineering."

Codexis, Inc. is a clean technology company. The company develops industrial biocatalysts, including enzymes and microbes, for the energy, pharmaceutical and environmental industries. Codexis serves major worldwide markets where clean technology can make a positive economic and environmental impact. For more information, visit www.codexis.com.

Contact: Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212-827-3771.

SOURCE Codexis, Inc.


'/>"/>
SOURCE Codexis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Veridiam Names Robert Mazzacavallo New CFO
2. Hospira Names Daphne E. Jones Chief Information Officer
3. Premier Research Names Bernard Sweeney as Executive Director, Medical Devices
4. American Hospital Association (AHA) Names OnBase RACTrac Compatible
5. ThermoGenesis Names Jorge Artiles Vice President, Chief Quality and Regulatory Affairs Officer
6. NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
7. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
8. ParagonRx Names Ellen M. Derrico To Chief Marketing Executive Post
9. Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO
10. California Cryobank Names Richard Jennings President of FamilyCord Division
11. Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 6.35% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition ... for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics ... HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded studies ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... Liberty attempts to compare student test score performance for the 2015-16 school year ... the state’s voucher programs. Though it highlights important patterns in student test score ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who ... achieves results in a fraction of the time as traditional braces – Wilckodontics®. ... Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Back ... neck and back pain with a reputable physician in their area, announces the launch ... protects patient information for patients who are looking for reputable physicians to help them ...
(Date:4/25/2017)... ... 25, 2017 , ... Somnoware, a leading provider of digital ... module. Using this new feature, sleep physicians can now predict the likelihood of ... airway pressure (CPAP), oral, or other forms of sleep apnea therapy. The Somnoware ...
Breaking Medicine News(10 mins):